IL91843A0 - Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids - Google Patents
Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aidsInfo
- Publication number
- IL91843A0 IL91843A0 IL91843A IL9184389A IL91843A0 IL 91843 A0 IL91843 A0 IL 91843A0 IL 91843 A IL91843 A IL 91843A IL 9184389 A IL9184389 A IL 9184389A IL 91843 A0 IL91843 A0 IL 91843A0
- Authority
- IL
- Israel
- Prior art keywords
- aids
- prophylaxis
- diagnosis
- therapy
- peptides useful
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25294988A | 1988-10-03 | 1988-10-03 | |
US35954389A | 1989-06-01 | 1989-06-01 | |
US40766389A | 1989-09-19 | 1989-09-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL91843A0 true IL91843A0 (en) | 1990-06-10 |
Family
ID=27400615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL91843A IL91843A0 (en) | 1988-10-03 | 1989-09-29 | Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0436634A1 (en) |
JP (1) | JPH04502760A (en) |
KR (1) | KR900701836A (en) |
AU (1) | AU640619B2 (en) |
DK (1) | DK57391A (en) |
FI (1) | FI911574A0 (en) |
IL (1) | IL91843A0 (en) |
NZ (1) | NZ230855A (en) |
PT (1) | PT91881A (en) |
WO (1) | WO1990003984A1 (en) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2627798A (en) * | 1951-08-27 | 1953-02-10 | William T Graham | Clamp for vibrating shank plows |
US2712781A (en) * | 1952-03-06 | 1955-07-12 | Glencoe Mfg Company | Mounting for earth tiller |
US2739518A (en) * | 1952-04-19 | 1956-03-27 | Glencoe Mfg Company | Shank holder |
US2775181A (en) * | 1953-08-17 | 1956-12-25 | Int Harvester Co | Spring mounted tool shank |
US3461971A (en) * | 1966-07-05 | 1969-08-19 | American Tractor Equip Corp | Vyba mount |
US5763160A (en) * | 1988-02-12 | 1998-06-09 | United Biomedical, Inc. | Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines |
US5562905A (en) * | 1988-04-26 | 1996-10-08 | E. I. Du Pont De Nemours And Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
CA2003383A1 (en) * | 1988-11-23 | 1990-05-23 | Sushil G. Devare | Synthetic dna derived recombinant hiv antigens |
JPH05506561A (en) * | 1989-06-05 | 1993-09-30 | レプリゲン・コーポレーション | HIV-1 MN gp120 human monoclonal antibody |
EP0448095A1 (en) * | 1990-03-21 | 1991-09-25 | Wolf, Hans Joachim, Prof. Dr. | Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections |
EP0532673A1 (en) * | 1990-06-08 | 1993-03-24 | Repligen Corporation | Immunoassays for anti-hiv-1 antibodies |
US5712373A (en) * | 1990-07-02 | 1998-01-27 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | HIV monoclonal antibody specific for the HTLV-IIImn gp120 envelope glycoprotein |
JP2989862B2 (en) * | 1990-07-02 | 1999-12-13 | 財団法人化学及血清療法研究所 | Monoclonal antibody |
CA2047078A1 (en) * | 1990-07-19 | 1992-01-20 | Steven S. Bondy | Cyclic hiv principal neutralizing determinant peptides |
CA2047073A1 (en) * | 1990-07-19 | 1992-01-20 | William J. Leanza | Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties |
CA2047031A1 (en) * | 1990-07-19 | 1992-01-20 | Stephen Marburg | Peptide-polysaccharide-protein conjugate vaccines |
CA2047033A1 (en) * | 1990-07-19 | 1992-01-20 | Elizabeth E. Sugg | Cyclic hiv principal neutralizing determinant peptides |
CA2047042A1 (en) * | 1990-07-19 | 1992-01-20 | John Hannah | Cyclic hiv principal neutralizing determinant peptides |
IL99077A0 (en) * | 1990-08-13 | 1992-07-15 | Merck & Co Inc | New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them |
IT1244529B (en) * | 1991-01-30 | 1994-07-15 | Ist Superiore Sanita | SYNTHETIC PEPTIDES SUITABLE TO ENHANCE THE INFECTIVITY OF THE HIV-1 VIRUS |
CA2083949A1 (en) * | 1991-04-02 | 1992-10-03 | Ayre Rubinstein | Therapeutic and preventive vaccines for hiv |
US6139843A (en) * | 1991-04-02 | 2000-10-31 | Albert Einstein College Of Medicine Of Yeshiva University | Peptide compositions for the treatment of HIV |
JPH0570493A (en) * | 1991-05-31 | 1993-03-23 | Chemo Sero Therapeut Res Inst | Immune prepared substance related to human immunodefiency virus (hiv) |
US5665569A (en) * | 1991-08-22 | 1997-09-09 | Nissin Shokuhin Kabushiki Kaisha | HIV immunotherapeutics |
EP0728015B1 (en) | 1992-06-18 | 2006-03-08 | Creagen, Inc. | Method of producing a set of combinatorial polypeptide antigens |
EP0588750A3 (en) * | 1992-08-05 | 1995-01-11 | Cigb | Method for the production of recombinant polypeptides bearing epitopes from different hiv isolates, and their uses as immunogens and in the detection of antibodies against hiv. |
FR2694938B1 (en) * | 1992-08-10 | 1996-11-15 | Zagury Jean Francois | NOVEL PEPTIDES, ANTIBODIES DIRECTED AGAINST SUCH PEPTIDES, ANTI-IDIOTYPIC ANTIBODIES, APPLICATION AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC KITS CONTAINING THEM. |
US5274122A (en) * | 1992-10-15 | 1993-12-28 | Merck & Co., Inc. | Acidic derivatives of homocysteine thiolactone |
US5563032A (en) * | 1992-10-21 | 1996-10-08 | The United States Of America As Represented By The Department Of Health And Human Services | Mosaic polypeptide and methods for detecting the hepatitis E virus |
WO1994018232A1 (en) * | 1993-02-12 | 1994-08-18 | Repligen Corporation | Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same |
EP0690132B1 (en) * | 1993-03-11 | 2003-12-17 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Anti-hiv monoclonal antibody |
NZ267838A (en) | 1993-06-07 | 1997-12-19 | Genentech Inc | Preparation of an hiv gp 120 subunit vaccine involving determining a neutralising epitope in the v2 and/or c4 domains |
US5643605A (en) * | 1993-10-25 | 1997-07-01 | Genentech, Inc. | Methods and compositions for microencapsulation of adjuvants |
US6913767B1 (en) | 1993-10-25 | 2005-07-05 | Genentech, Inc. | Compositions for microencapsulation of antigens for use as vaccines |
US6080429A (en) * | 1993-10-25 | 2000-06-27 | Genentech, Inc. | Method for drying microspheres |
DE4405810A1 (en) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Peptides derived from a retrovirus from the HIV group and their use |
US6585979B1 (en) * | 1996-07-08 | 2003-07-01 | Genentech, Inc. | HIV envelope polypeptides and immunogenic composition |
US6689879B2 (en) | 1998-12-31 | 2004-02-10 | Chiron Corporation | Modified HIV Env polypeptides |
US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
EP1141314A2 (en) | 1998-12-31 | 2001-10-10 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
AU2221600A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
EP1214097B3 (en) * | 1999-09-16 | 2011-07-20 | Eisai Inc. | Nucleic acids encoding polyepitope polypeptides |
JP5033303B2 (en) | 2001-07-05 | 2012-09-26 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | Polynucleotides encoding polypeptides with antigenic type C HIV, polypeptides and uses thereof |
WO2003020876A2 (en) | 2001-08-31 | 2003-03-13 | Chiron Corporation | Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
US20030170614A1 (en) | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
KR100466382B1 (en) * | 2002-01-08 | 2005-01-14 | 주식회사 엘지생명과학 | Recombinant combo protein fused in HIV type-1 and -2, manufacturing method thereof, vector, transformant and diagnostic kit thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3689941D1 (en) * | 1985-10-24 | 1994-08-04 | Southwest Found Biomed Res | SYNTHETIC PEPTIDES AND THEIR USE FOR DIAGNOSIS AND VACCINATION FOR AIDS AND ARC. |
AU617088B2 (en) * | 1986-06-12 | 1991-11-21 | Biogen, Inc. | Peptides involved in the pathogenesis of hiv infection |
AU7786387A (en) * | 1986-07-21 | 1988-02-10 | Southwest Foundation For Biomedical Research | Composition of matter and method of immunizing against viral causative agents of aids and arc |
NZ221440A (en) * | 1986-08-20 | 1991-11-26 | Genetic Systems Corp | Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections |
WO1988005051A1 (en) * | 1986-12-30 | 1988-07-14 | United States Of America, Represented By The Unite | Synthetic peptides which induce cellular immunity of the aids virus and aids viral proteins |
JP2520464B2 (en) * | 1987-05-29 | 1996-07-31 | タノツクス・バイオシステムズ・インコーポレーテツド | Monoclonal antibody that neutralizes HIV-1 |
FR2619012B1 (en) * | 1987-08-07 | 1989-12-22 | Pasteur Institut | VACCINES IN WHICH THE CHARACTERISTIC EPITOPE IS INCORPORATED IN A PROTEIN OF PICORNAVIRUS, ESPECIALLY POLIOVIRUS |
IL87391A0 (en) * | 1987-08-27 | 1989-01-31 | Repligen Corp | Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them |
NL8702403A (en) * | 1987-10-09 | 1989-05-01 | Stichting Centr Diergeneeskund | OLIGOPEPTIDES AND THEIR USE FOR DIAGNOSTIC AND VACCINATION PURPOSES FOR AIDS AND ARC. |
-
1989
- 1989-09-29 IL IL91843A patent/IL91843A0/en unknown
- 1989-09-29 AU AU44036/89A patent/AU640619B2/en not_active Ceased
- 1989-09-29 EP EP89911309A patent/EP0436634A1/en not_active Withdrawn
- 1989-09-29 KR KR1019900701182A patent/KR900701836A/en not_active Application Discontinuation
- 1989-09-29 JP JP1510567A patent/JPH04502760A/en active Pending
- 1989-09-29 WO PCT/US1989/004302 patent/WO1990003984A1/en not_active Application Discontinuation
- 1989-10-02 NZ NZ230855A patent/NZ230855A/en unknown
- 1989-10-03 PT PT91881A patent/PT91881A/en unknown
-
1991
- 1991-04-02 FI FI911574A patent/FI911574A0/en not_active Application Discontinuation
- 1991-04-02 DK DK057391A patent/DK57391A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU640619B2 (en) | 1993-09-02 |
EP0436634A1 (en) | 1991-07-17 |
DK57391A (en) | 1991-05-29 |
DK57391D0 (en) | 1991-04-02 |
AU4403689A (en) | 1990-05-01 |
KR900701836A (en) | 1990-12-04 |
PT91881A (en) | 1990-04-30 |
NZ230855A (en) | 1994-10-26 |
JPH04502760A (en) | 1992-05-21 |
FI911574A0 (en) | 1991-04-02 |
WO1990003984A1 (en) | 1990-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL91843A0 (en) | Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids | |
GB2221300B (en) | Enzyme electrodes and improvements in the manufacture thereof | |
AU617088B2 (en) | Peptides involved in the pathogenesis of hiv infection | |
AU6399786A (en) | Polypeptides used in the diagnosis and therapy of AIDS | |
NZ224046A (en) | Hiv antigenic peptide fragments and their use | |
ZA886273B (en) | Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids | |
AU6428890A (en) | Therapeutic peptides and proteins | |
GB2203740B (en) | Novel peptides, their preparation and use | |
AU1382488A (en) | Cyclic peptides and their preparation | |
NZ227594A (en) | Human interleukin-1alpha and preparations thereof | |
NZ224393A (en) | Recombinant hiv envelope proteins and uses thereof | |
IL86796A0 (en) | Peptide derivatives,their preparation and their use | |
ZA888701B (en) | Expression of hiv proteins in e.coli and s. cerevisiae | |
ZA897509B (en) | Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids | |
AU2738088A (en) | Soluble recombinant fce-receptor, the preparation and the use thereof | |
EG18799A (en) | Phenylthioureas, phenylisothioureas and phenylcarbodumides their preparation and use in the control of pests | |
AU1676288A (en) | Human immunodeficiency virus gag-encoded proteins | |
GR900300003T1 (en) | 3-aminodihydrothiophene-2-one peptide derivatives, processes for the preparation and therapeutic use | |
AU4096889A (en) | The use of lactam derivatives in the treatment of depression | |
ZA889506B (en) | Soluble recombinant fce-receptor,the preparation and the use thereof | |
IL89993A0 (en) | Expression of the hiv 24kda gag protein in methylotrophic yeasts | |
AU6848687A (en) | Use of oligopeptides in the treatment of viral infections | |
IL86983A0 (en) | Pyridylthio-,pyridylsulfinyl-and pyridylsulfonyl-phenyl-thioureas,isothioureas and-carbodiimides,their preparation and use in the control of pests | |
IE891349L (en) | EXPRESSION OF THE HIV kDa GAG PROTEIN IN YEAST | |
AU8260287A (en) | N-phenyl-N-carboxythioureas and their use in the control of pests |